DVA — DaVita Inc
NYSE · Health Care · Health Care
- Latest Close
- $151.85
- 30-Day Move
- +28.2%
- Market Cap
- $9.7B
- Shares Outstanding
- 66,800,000
- P/E Ratio
- 13.02
- P/B Ratio
- 101.25
DaVita Inc
A read-only Alphactor snapshot forDaVita Inc. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.
Snapshot as of2026-04-24
Topline snapshot
Latest Close
$151.85
30-Day Move
+28.2%
Market Cap
$9.7B
Shares Outstanding
66,800,000
P/E Ratio
13.02
P/B Ratio
101.25
$151.85
+28.2%last 90 delayed daily bars
90D High
$159.42
90D Low
$101.00
Avg Volume
954,543
Gross margin is running at 32.3%, which gives a quick read on operating quality before you open the full model.
Net margin is 5.5%, useful for comparing DVA against peers in Health Care.
DVA is up 28.2% over the last 30 trading days shown on this page.
Latest operating income is $551M, which helps anchor the headline ratios with an actual earnings figure.
Composite Fair Value
$329.60
Rule of 40
16.1%
Dark Pool Short %
67.7%
Latest Close
$151.85
30-Day Move
+28.2%
Market Cap
$9.7B
Shares Outstanding
66,800,000
P/E Ratio
13.02
P/B Ratio
101.25
ROE
773.1%
ROA
4.3%
Gross Margin
32.3%
Operating Margin
14.9%
Net Margin
5.5%
Debt / Equity
77.99
Current Ratio
1.29
Latest Revenue
$3.6B
Revenue
$3.6B
Gross Profit
$1.2B
Operating Income
$551M
Net Income
$234M
Gross Margin
3225.0%
Net Margin
547.0%
Current Ratio
1.29
Debt / Equity
77.99
Fair Value
$329.60
Upside / Downside
+117.1%
Signal
Undervalued
Implied Growth
5.6%
DCF
$110.84
EPV
$39.39
EV/Rev
$838.58
Growth Assumption
5.5%
Discount Rate
9.9%
Terminal Growth
2.0%
Base FCF
$1.3B
Valuation spread
After signup
The full valuation workspace goes deeper
Adjust DCF growth, discount, and terminal assumptions instead of relying on one static snapshot.
Open the deeper balance-sheet and cash-flow views to inspect debt, liquidity, and cash generation line by line.
Compare multiple valuation models against peers and save your own thesis instead of re-reading a fixed public state.
Low growth priced in
Altman Z
1.55
Distress
Piotroski
6
Moderate (4-6)
Cash Conversion
2.53x
Rule of 40
16.1%
Concerning
Annual performance mix
| Period | Revenue | Operating Income | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2022-12-31 | $11.6B | $1.3B | $560M | $961M |
| 2023-12-31 | $12.1B | $1.6B | $692M | $1.5B |
| 2024-12-31 | $12.8B | $2.0B | $936M | $1.5B |
| 2025-12-31 | $13.6B | $2.0B | $747M | $1.3B |
After signup
The app opens the full statement deep dive
Extend the history well beyond this public snapshot to inspect longer cycles and regime changes.
Move from summary lines into detailed balance-sheet and cash-flow rows for working capital, debt, and capex analysis.
Cross-link statement changes with alerts, watchlists, and saved research workflows after signup.
Buy Value
$0
Sell Value
$681M
Buys
0
Sells
13
Buy Value
$0
Sell Value
$681M
Buy/Sell Ratio
0.00x
After signup
The full app goes deeper on insider behavior
Inspect longer insider history, recurring buyers and sellers, and the broader transaction context beyond this snapshot.
Continue into deeper institutional and alternative-data views once you sign up.
| Date | Name | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-15 | Maughan David Paul | A | 14,351 | $0.00 |
| 2026-03-15 | Maughan David Paul | F | 7,768 | $150.72 |
| 2026-03-15 | Maughan David Paul | F | 5,339 | $150.72 |
| 2026-03-15 | Maughan David Paul | A | 5,308 | $0.00 |
| 2026-03-15 | Pullin Dennis W | A | 332 | $0.00 |
| 2026-03-15 | Moore Gregory J. | A | 332 | $0.00 |
| 2026-03-15 | HEARTY JAMES O | A | 3,050 | $0.00 |
| 2026-03-15 | HEARTY JAMES O | F | 1,525 | $150.72 |
| ETF | Shares | Weight | As Of |
|---|---|---|---|
| Invesco Exchange-Traded Fund Trust-Invesco S&P 500 Equal Weight ETF | 1,434,963 | 0.02% | 2026-02-28 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1,120,309 | 0.02% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 888,251 | 0.01% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 800,707 | 0.01% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund | 516,493 | 0.01% | 2025-12-31 |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | 449,232 | 0.01% | 2026-02-28 |
| iShares Trust-iShares Core S&P 500 ETF | 449,397 | 0.01% | 2026-02-28 |
| SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust | 378,511 | 0.01% | 2026-03-31 |
After signup
The deeper ownership view shows who is leaning in
Open richer institutional and holder diffs to see position changes across filings instead of one static snapshot.
Use those ownership shifts alongside conviction and alerts in the full app workflow.
Qube Research & Technologies
Filed 2025-11-14
--
--
Berkshire Hathaway
Filed 2025-08-14
$4.8B
--
Vanguard Group
Filed 2025-05-09
$773M
-3.1%
BlackRock
Filed 2024-08-13
$685M
--
Invesco
Filed 2025-08-13
$235M
+0.2%
For informational and educational purposes only. Not financial advice. Learn more
Related reading
Research and strategy guides from the alphactor blog.
Healthcare Investing: Pharma, Biotech, and the FDA Calendar
A framework for navigating healthcare stocks across pharma, biotech, and medical devices, with emphasis on regulatory catalysts and pipeline valuation.
Accruals Quality: How to Spot Earnings That Aren't Real
Accruals measure the gap between reported earnings and actual cash. Widening accruals is one of the most reliable red flags in financial analysis — Sloan's…
Altman Z-Score: A Bankruptcy Predictor That Still Works
Edward Altman's 1968 discriminant model predicts bankruptcy within two years about 72% of the time at its distress threshold.